DNA macrorestriction profiles and antifungal susceptibility of Candida (Torulopsis) glabrata

被引:12
|
作者
Cormican, MG [1 ]
Hollis, RJ [1 ]
Pfaller, MA [1 ]
机构
[1] UNIV IOWA,COLL MED,DEPT PATHOL,DEPT MED MICROBIOL,IOWA CITY,IA 52242
关键词
D O I
10.1016/S0732-8893(96)00083-1
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Candida (Torulopsis) glabrata is an emerging nosocomial pathogen that may be relatively resistant to fluconazole. A series of 75 isolates (blood, urine, tissue, and other sites) from 16 patients (1 to 12 isolates per patient) at a single university medical center were analyzed by pulsed field gel electrophoresis (PFGE) of restriction endonuclease digests of chromosomal DNA. The MICs of the isolates for amphotericin B, flucytosine, fluconazole, and itraconazole, were determined by a microdilution broth method. A preliminary study of seven restriction enzymes, three producing small fragments (Hinf I, Hind III, Eco XI) and four producing large fragments (fag I, BssH II, Sfi I, Not I) identified Not I as giving interpretable banding patterns. Isolates were considered of different types if they differed by two or move bands. Sixteen distinct DNA types (A to P) were identified. Karyotyping was used an additional technique to compare strains with a common PFGE type. Most patients were colonized or infected with a single type at multiple body sites and over time. One PFGE type was shared by four patients housed in different areas of the institution at different times. For two of these four patients, the karyotype was also indistintuishable. Five patients were each colonized with two distinct types. The MIC of the strains studied were amphotericin B 0.5-1.0 mu g/ml (MIC(90) = 1.0 mu g/ ml), 5-fluorocytosine 0.25 --> 256 mu g/ml (MIC(90) = 2 mu g/ml), fluconazole 0.25 --> 128 mu g/ml (MIC(90) = 32 mu g/ml), and itraconazole 0.06-8.0 mu g/ml (MIC(90) = 2.0 mu g/ml). Molecular typing by PFGE using Not I digestion is It useful technique for epidemiological investigation as epidemiologically related isolates are generally identical and epidemiologically unrelated isolates are different by this method.
引用
收藏
页码:83 / 87
页数:5
相关论文
共 50 条
  • [41] ANTIGEN RELATIONSHIPS BETWEEN CANDIDA-ALBICANS AND TORULOPSIS-GLABRATA
    FAGGI, E
    GARGANI, G
    ANNALI SCLAVO, 1975, 17 (02): : 187 - 190
  • [42] Pathogenicity of Candida tropicalis, Candida krusei and Torulopsis (Candida) glabrata for outbred CFW1 mice
    Schmidt, A
    JOURNAL DE MYCOLOGIE MEDICALE, 1996, 6 (03): : 133 - 135
  • [43] Torulopsis (Candida) glabrata: A new pathogen bound in spinal epidural abscess
    Bonomo, RA
    Strauss, M
    Blinkhorn, R
    Salata, RA
    CLINICAL INFECTIOUS DISEASES, 1996, 22 (03) : 588 - 589
  • [44] ANTIGENIC RELATIONSHIPS OF TORULOPSIS-GLABRATA AND 7 SPECIES OF THE GENUS CANDIDA
    HASENCLEVER, HF
    MITCHELL, WO
    JOURNAL OF BACTERIOLOGY, 1960, 79 (05) : 677 - 681
  • [45] Prevalence, distribution and antifungal susceptibility profiles of Candida parapsilosis, Candida orthopsilosis and Candida metapsilosis bloodstream isolates
    Bonfietti, Lucas Xavier
    Martins, Marilena dos Anjos
    Szeszs, Maria Walderez
    Stolf Pukiskas, Sandra Brasil
    Purisco, Sonia Ueda
    Pimentel, Fabiana Cortez
    Pereira, Graziella Hanna
    Silva, Dayane Cristina
    Oliveira, Lidiane
    Carvalho Melhem, Marcia de Souza
    JOURNAL OF MEDICAL MICROBIOLOGY, 2012, 61 (07) : 1003 - 1008
  • [46] INVITRO ANTIFUNGAL ACTIVITY OF KETOCONAZOLE AND AMPHOTERICIN-B AGAINST TORULOPSIS GLABRATA AND CANDIDA SPECIES FROM CANCER-PATIENTS
    WALSH, TJ
    MOODY, MM
    WHARTON, RC
    SPRECHER, S
    SCHIMPFF, SC
    WADE, JC
    CLINICAL RESEARCH, 1984, 32 (02): : A386 - A386
  • [47] Antifungal Susceptibility Testing Identifies the Abdominal Cavity as a Source of Candida glabrata-Resistant Isolates
    Diaz-Garcia, Judith
    Mesquida, Aina
    Gomez, Ana
    Machado, Marina
    Martin-Rabadan, Pablo
    Alcala, Luis
    Sanchez-Carrillo, Carlos
    Reigadas, Elena
    Vicente, Teresa
    Munoz, Patricia
    Escribano, Pilar
    Guinea, Jesus
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (12)
  • [48] Molecular epidemiology, antifungal susceptibility and virulence factors of Candida glabrata complex strains in Kayseri/Turkey
    Kaan, Ozge
    Koc, A. Nedret
    Atalay, Mustafa Altay
    Sariguzel, Fatma Mutlu
    MICROBIAL PATHOGENESIS, 2021, 154
  • [49] Increasing Trends of Reduced Susceptibility to Antifungal Drugs Among Clinical Candida glabrata Isolates in Kuwait
    Khan, Ziauddin
    Ahmad, Suhail
    Al-Sweih, Noura
    Mokaddas, Eiman
    Al-Banwan, Khalifa
    Alfouzan, Wadha
    Al-Obaid, Inaam
    Al-Obaid, Khaled
    Varghese, Soumya
    MICROBIAL DRUG RESISTANCE, 2020, 26 (08) : 982 - 990
  • [50] Application of CHROMagar Candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei, and Candida (Torulopsis) glabrata
    Pfaller, MA
    Houston, A
    Coffmann, S
    JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (01) : 58 - 61